CH3 BioSystems LLC is a biotechnology company based in Buffalo, NY, specializing in the development and commercialization of unique products and molecular tools for biomedical research. With a focus on cancer, autoimmune, neurodevelopmental, viral, and cardiovascular diseases, CH3 BioSystems aims to provide innovative solutions for a better understanding of these conditions and the development of diagnostic and pharmaceutical products.
Utilizing their patented chemical technology, CH3 BioSystems offers a wide range of products, including cell lines, antibodies, enzymes, peptides, and vectors, all designed to facilitate disease research and epigenetic regulation. With a global network of manufacturing and distribution, CH3 BioSystems is committed to advancing the field of protein methylation biology and improving the lives of millions of people worldwide.
Generated from the website
